| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $1.48 | $1.40 | $1.55 | $1.37 | $1.45 | $0.75 | $1.07 | $1.09 |
| EPS (Diluted) | $1.47 | $1.39 | $1.54 | $1.37 | $1.44 | $0.75 | $1.07 | $1.08 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.3B | $11.6B | $11.5B | $9.8B | $9.5B | $9.1B | $8.3B | $7.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.1B | $0.1B |
| Total Liabilities | $10.8B | $10.2B | $10.1B | $8.8B | $8.4B | $8.0B | $7.3B | $6.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.6B | $1.4B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.1B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.4B | $-0.1B | $-0.6B | $-0.6B | $-0.6B | $-0.5B | $0.1B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.2B | $-0.0B | $0.4B | $0.2B | $0.4B | $0.6B | $-0.2B | $0.2B |